NANO MRNAの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/06/11 | 1,168 | 1,229 | 1,146 | 1,229 | +31 | +2.6% | 463,200 |
2014/06/10 | 1,250 | 1,252 | 1,198 | 1,198 | -59 | -4.7% | 353,800 |
2014/06/09 | 1,272 | 1,277 | 1,245 | 1,257 | +10 | +0.8% | 286,700 |
2014/06/06 | 1,245 | 1,256 | 1,202 | 1,247 | -10 | -0.8% | 479,300 |
2014/06/05 | 1,310 | 1,314 | 1,234 | 1,257 | -66 | -5% | 626,500 |
2014/06/04 | 1,370 | 1,370 | 1,312 | 1,323 | +31 | +2.4% | 730,800 |
2014/06/03 | 1,316 | 1,333 | 1,270 | 1,292 | -18 | -1.4% | 786,600 |
2014/06/02 | 1,288 | 1,310 | 1,256 | 1,310 | +73 | +5.9% | 664,000 |
2014/05/30 | 1,214 | 1,299 | 1,208 | 1,237 | +33 | +2.7% | 988,400 |
2014/05/29 | 1,200 | 1,228 | 1,190 | 1,204 | +44 | +3.8% | 638,300 |
2014/05/28 | 1,173 | 1,193 | 1,136 | 1,160 | +17 | +1.5% | 463,200 |
2014/05/27 | 1,151 | 1,216 | 1,135 | 1,143 | +45 | +4.1% | 1,171,400 |
2014/05/26 | 1,067 | 1,125 | 1,061 | 1,098 | +67 | +6.5% | 639,600 |
2014/05/23 | 1,013 | 1,065 | 1,000 | 1,031 | +41 | +4.1% | 658,800 |
2014/05/22 | 915 | 990 | 912 | 990 | +90 | +10% | 708,700 |
2014/05/21 | 891 | 921 | 885 | 900 | -18 | -2% | 457,600 |
2014/05/20 | 900 | 932 | 891 | 918 | +11 | +1.2% | 509,900 |
2014/05/19 | 965 | 974 | 902 | 907 | -67 | -6.9% | 562,400 |
2014/05/16 | 990 | 1,010 | 962 | 974 | -67 | -6.4% | 587,100 |
2014/05/15 | 1,060 | 1,060 | 1,012 | 1,041 | +11 | +1.1% | 273,600 |
2014/05/14 | 1,000 | 1,075 | 970 | 1,030 | ±0 | ±0% | 452,100 |
2014/05/13 | 1,000 | 1,047 | 997 | 1,030 | +75 | +7.9% | 500,500 |
2014/05/12 | 1,000 | 1,025 | 955 | 955 | -56 | -5.5% | 449,600 |
2014/05/09 | 1,022 | 1,038 | 1,002 | 1,011 | -30 | -2.9% | 346,000 |
2014/05/08 | 1,079 | 1,083 | 1,031 | 1,041 | -18 | -1.7% | 267,100 |
2014/05/07 | 1,095 | 1,103 | 1,059 | 1,059 | -66 | -5.9% | 377,800 |
2014/05/02 | 1,091 | 1,170 | 1,091 | 1,125 | +14 | +1.3% | 448,100 |
2014/05/01 | 1,070 | 1,127 | 1,050 | 1,111 | +67 | +6.4% | 605,000 |
2014/04/30 | 1,095 | 1,107 | 1,017 | 1,044 | -69 | -6.2% | 634,500 |
2014/04/28 | 1,183 | 1,188 | 1,103 | 1,113 | -94 | -7.8% | 551,200 |
2014/04/25 | 1,219 | 1,239 | 1,205 | 1,207 | -5 | -0.4% | 231,400 |
2014/04/24 | 1,218 | 1,239 | 1,203 | 1,212 | -12 | -1% | 182,100 |
2014/04/23 | 1,218 | 1,230 | 1,192 | 1,224 | +23 | +1.9% | 236,900 |
2014/04/22 | 1,220 | 1,239 | 1,197 | 1,201 | -29 | -2.4% | 269,200 |
2014/04/21 | 1,285 | 1,287 | 1,230 | 1,230 | -31 | -2.5% | 214,000 |
2014/04/18 | 1,269 | 1,269 | 1,240 | 1,261 | -7 | -0.6% | 282,700 |
2014/04/17 | 1,319 | 1,330 | 1,266 | 1,268 | -39 | -3% | 430,600 |
2014/04/16 | 1,221 | 1,324 | 1,212 | 1,307 | +101 | +8.4% | 707,500 |
2014/04/15 | 1,230 | 1,237 | 1,201 | 1,206 | -5 | -0.4% | 289,900 |
2014/04/14 | 1,209 | 1,260 | 1,205 | 1,211 | -28 | -2.3% | 384,100 |
2014/04/11 | 1,210 | 1,245 | 1,190 | 1,239 | -50 | -3.9% | 583,500 |
2014/04/10 | 1,346 | 1,385 | 1,260 | 1,289 | -35 | -2.6% | 546,500 |
2014/04/09 | 1,340 | 1,363 | 1,305 | 1,324 | -48 | -3.5% | 381,500 |
2014/04/08 | 1,379 | 1,410 | 1,345 | 1,372 | -28 | -2% | 476,000 |
2014/04/07 | 1,451 | 1,460 | 1,393 | 1,400 | -100 | -6.7% | 366,200 |
2014/04/04 | 1,510 | 1,529 | 1,481 | 1,500 | -29 | -1.9% | 349,400 |
2014/04/03 | 1,636 | 1,652 | 1,521 | 1,529 | -91 | -5.6% | 793,800 |
2014/04/02 | 1,545 | 1,624 | 1,537 | 1,620 | +140 | +9.5% | 834,900 |
2014/04/01 | 1,414 | 1,490 | 1,402 | 1,480 | +71 | +5% | 577,400 |
2014/03/31 | 1,450 | 1,455 | 1,372 | 1,409 | -4 | -0.3% | 394,000 |
2701~
2750
件表示中 / 3730件
類似銘柄と比較する
現在ご覧いただいている「NANO」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
NANO | 13,900円 | -30.6% | - | 0.00% | - | 3.60倍 |
|
mRNA医薬品に特化した創薬ベンチャー。創薬シーズ発掘から臨床開発まで手がけて導出 |
カイオム | 15,200円 | +92.3% | - | 0.00% | - | 5.42倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
坪田ラボ | 39,600円 | +3.2% | -21.7% | 0.00% | 67.69倍 | 6.40倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
メディシノバ | 19,000円 | - | - | - | - | - |
|
- |
ソレイジア | 4,000円 | +311.4% | - | 0.00% | - | 7.68倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
市場注目の銘柄
チャート関連のコラム